Antisense inhibition of dual specific phosphatase 9 expression

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6566133
APP PUB NO 20030083285A1
SERIAL NO

09922146

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antisense compounds, compositions and methods are provided for modulating the expression of Dual specific phosphatase 9. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Dual specific phosphatase 9. Methods of using these compounds for modulation of Dual specific phosphatase 9 expression and for treatment of diseases associated with expression of Dual specific phosphatase 9 are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ISIS PHARMACEUTICALS INC1896 RUTHERFORD ROAD CARLSBAD CA 92008

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cowsert, Lex M San Mateo, CA 219 3636

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation